Berhow M T, Hiroi N, Nestler E J
Department of Psychiatry, Yale University School of Medicine, Connecticut Mental Health Center, New Haven 06508, USA.
J Neurosci. 1996 Aug 1;16(15):4707-15. doi: 10.1523/JNEUROSCI.16-15-04707.1996.
Local infusion of brain-derived neurotrophic factor (BDNF) into the ventral tegmental area (VTA) can prevent and reverse the ability of chronic morphine or cocaine exposure to induce tyrosine hydroxylase (TH) in this brain region. The present study examined a possible role for extracellular signal regulated kinases (ERKs), the major effector for BDNF and related neurotrophins, in morphine and cocaine action in the VTA. Chronic, but not acute, administration of morphine or cocaine increased ERK catalytic activity specifically in the VTA. This increase in ERK activity reflected an increase in the state of phosphorylation of ERK, with no change in levels of total ERK immunoreactivity. Chronic infusions of BDNF into the VTA reduced total ERK immunoreactivity with no change in ERK activity, and also blocked the morphine-induced increase in ERK activity. These results suggest that chronic BDNF elicits a compensatory increase in the phosphorylation of the remaining ERK molecules and thereby prevents any additional increase in response to drug exposure. Such a role for ERK in morphine action was demnostrated directly by chronically infusing antisense oligonucleotides to ERK1 into the VTA. This treatment selectively reduced levels of ERK1 immunoreactivity in a sequence-specific manner without detectable toxicity. Intra-VTA infusion of ERK1 antisense oligonucleotides mimicked the effects of chronic BDNF infusions on ERK immunoreactivity, ERK activity, and TH immunoreactivity in the VTA under both control and morphine-treated conditions. The chronic morphine-induced increases in ERK activity and TH expression in the VTA also were blocked by local infusion of NMDA glutamate receptor antagonists, suggesting a role for glutamate in mediating these drug effects. Together, these findings support a scheme whereby chronic, systemic administration of morphine or cocaine leads to a sustained increase in ERK phosphorylation state and activity in the VTA, which, in turn, contributes to drug-induced increases in TH, and perhaps other drug-induced adaptations, elicited selectively in this brain region.
将脑源性神经营养因子(BDNF)局部注入腹侧被盖区(VTA),可以预防并逆转慢性吗啡或可卡因暴露诱导该脑区酪氨酸羟化酶(TH)的能力。本研究探讨了细胞外信号调节激酶(ERKs)作为BDNF及相关神经营养因子的主要效应分子,在VTA中吗啡和可卡因作用过程中可能发挥的作用。慢性而非急性给予吗啡或可卡因,可特异性增加VTA中ERK的催化活性。ERK活性的这种增加反映了ERK磷酸化状态的增强,而总ERK免疫反应性水平未发生变化。向VTA慢性注入BDNF可降低总ERK免疫反应性,但ERK活性不变,同时还能阻断吗啡诱导的ERK活性增加。这些结果表明,慢性BDNF引发了剩余ERK分子磷酸化的代偿性增加,从而防止了对药物暴露的进一步反应增加。通过向VTA慢性注入ERK1反义寡核苷酸,直接证明了ERK在吗啡作用中的这种作用。这种处理以序列特异性方式选择性降低了ERK1免疫反应性水平,且未检测到毒性。在对照和吗啡处理条件下,向VTA内注入ERK1反义寡核苷酸模拟了慢性注入BDNF对VTA中ERK免疫反应性、ERK活性和TH免疫反应性的影响。局部注入NMDA谷氨酸受体拮抗剂也可阻断慢性吗啡诱导的VTA中ERK活性和TH表达增加,提示谷氨酸在介导这些药物效应中发挥作用作用。总之,这些发现支持了这样一种机制,即慢性全身性给予吗啡或可卡因会导致VTA中ERK磷酸化状态和活性持续增加,进而导致药物诱导的TH增加,以及可能在该脑区选择性引发的其他药物诱导适应性变化。